Abstract # 2588 A Phase I/II Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of MTS-01 for the Prevention of Alopecia Induced by Whole Brain Radiotherapy (WBRT)

Presenter: Metz, James

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

J. M. Metz*1, D. Smith*1, R. Mick*1, R. Lustig*1, B. Stea*2, J. Mitchell*3, M. Cherakuri*3, E. Glatstein*1, S. M. Hahn*1. , 1University of Pennsylvania Medical Ctr., Philadelphia, PA, 2University of Arizona, Tucson, AZ, 3National Cancer Institute, Bethesda, MD,

Author Disclosure:
J.M. Metz, Mitos Pharmaceuticals, F. Consultant/Advisory Board; D. Smith, None; R. Mick, None; R. Lustig, None; B. Stea, None; J. Mitchell, None; M. Cherakuri, None; E. Glatstein, None; S.M. Hahn, Mitos Pharmaceuticals, F. Consultant/Advisory Board; Patent, G. Other.

E-mail a friend about this abstract:
Enter email address:   

Abstracts Main Page | Logout